Request for Nominations of Candidates To Serve on the Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC)-Health Disparities Subcommittee (HDS), 60355-60356 [2016-21039]

Download as PDF Federal Register / Vol. 81, No. 170 / Thursday, September 1, 2016 / Notices 1. The Stephen L. LaFrance, Jr. GW Investments Trust, the Jason P. LaFrance GW Investments Trust, the Amy Beth LaFrance GW Investments Trust, all of Little Rock, Arkansas, Stephen L. LaFrance, Jr., Little Rock, Arkansas, as trustee of the Stephen L. LaFrance, Jr. GW Investments Trust and co-trustee of the Jason P. LaFrance GW Investments Trust, and Jason P. LaFrance, Little Rock, Arkansas, as cotrustee of the Jason P. LaFrance GW Investments Trust and as trustee of the Amy Beth LaFrance GW Investments Trust and the Amy LaFrance Bancroft GW Investments Revocable Trust, Little Rock, Arkansas; to acquire voting shares of Greenwoods Financial Group, Inc., Lake Mills, Wisconsin, and thereby join the existing LaFrance Family Control Group that was approved to acquire 10 percent or more of the outstanding shares of Greenwoods Financial Group, Inc. Greenwoods Financial Group, Inc. controls The Greenwood’s State Bank, Lake Mills, Wisconsin. Board of Governors of the Federal Reserve System, August 26, 2016. Michele Taylor Fennell, Assistant Secretary of the Board. [FR Doc. 2016–21009 Filed 8–31–16; 8:45 am] FEDERAL RESERVE SYSTEM asabaliauskas on DSK3SPTVN1PROD with NOTICES Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise 17:14 Aug 31, 2016 Jkt 238001 Board of Governors of the Federal Reserve System, August 26, 2016. Michele Taylor Fennell, Assistant Secretary of the Board. [FR Doc. 2016–21010 Filed 8–31–16; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention BILLING CODE 6210–01–P VerDate Sep<11>2014 noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than September 26, 2016. A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. Canadian Imperial Bank of Commerce, Toronto, Canada and its wholly-owned subsidiary, CIBC Holdco Inc., New York, New York; to acquire PrivateBancorp, Inc. and thereby indirectly acquire The PrivateBank and Trust Company, both in Chicago, Illinois. Request for Nominations of Candidates To Serve on the Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC)—Health Disparities Subcommittee (HDS) The Centers for Disease Control and Prevention (CDC) is soliciting nominations for possible membership on the ACD, CDC–HDS. This subcommittee consists of up to 16 experts in fields related to health policy, public health, global health, preparedness, preventive medicine, the faith-based and community-based sector, and allied fields who are selected by the CDC. The HDS provides interdisciplinary perspectives and subject matter expertise to the goal of reducing health disparities which may include research, program and policy analyses, and other developmental activities for the ACD, CDC on CDC’s efforts to address health disparities which is integral to achieving the agency’s overarching health impact goals. Specifically, the HDS will submit work products to the ACD, CDC for deliberation, discussion, and decision. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishment of the subcommittee’s mission. Nominees will PO 00000 Frm 00018 Fmt 4703 Sfmt 4703 60355 be selected by the Designated Federal Officer of the ACD, CDC. Members may be invited to serve for terms of up to three years. The U.S. Department of Health and Human Services policy stipulates that committee membership shall be balanced in terms of professional training and background, points of view represented, and the committee’s function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Subcommittee members are Special Government Employees, requiring the filing of financial disclosure reports at the beginning and annually during their terms. Note that the need for different expertise varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Candidates should submit the following items: D Current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address). D At least one letter of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. (Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency (e.g., CDC, NIH, FDA, etc.). Nomination materials must be date stamped by midnight on September 30, 2016 and sent to: ACDirector@cdc.gov or to Tracie Strength, Office of the Chief of Staff, Centers for Disease Control and Prevention, 1600 Clifton Road NE., Mailstop D14, Atlanta, Georgia 30329. Please direct questions to Tracie Strength at (404)498–6482. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and E:\FR\FM\01SEN1.SGM 01SEN1 60356 Federal Register / Vol. 81, No. 170 / Thursday, September 1, 2016 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2016–21039 Filed 8–31–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Tribal Consultation Meetings Office of Head Start (OHS), Administration for Children and Families, Department of Health and Human Services. ACTION: Notice of meeting. AGENCY: Pursuant to the Improving Head Start for School Readiness Act of 2007, Public Law 110–134, notice is hereby given of a 1-day Tribal Consultation Session to be held between the Department of Health and Human Services (HHS), Administration for Children and Families, OHS leadership and the leadership of Tribal Governments operating Head Start (including Early Head Start) programs. The purpose of these Consultation Sessions is to discuss ways to better meet the needs of American Indian and Alaska Native children and their families, taking into consideration funding allocations, distribution formulas, and other issues affecting the delivery of Head Start services in their geographic locations [42 U.S.C. 9835, Section 640(l)(4)]. DATES: October 19, 2016, from 8:00 a.m. to 1:00 p.m. LOCATION: ThrivAlaska Head Start Center at 1949 Gilliam Way, Fairbanks, Alaska 99701. FOR FURTHER INFORMATION CONTACT: Angie Godfrey, Regional Program Manager, Region XI AI/AN, OHS, email Angie.Godfrey@acf.hhs.gov, or phone (202) 205–5811. Additional information and online meeting registration is available at: https:// eclkc.ohs.acf.hhs.gov/hslc/hs/calendar/ tc2016. asabaliauskas on DSK3SPTVN1PROD with NOTICES SUMMARY: HHS announces OHS Tribal Consultations for leaders of Tribal Governments operating Head Start and Early Head Start programs. The agenda for the scheduled OHS Tribal Consultations in Fairbanks, Alaska, will be organized around the statutory purposes of Head Start Tribal Consultations related to meeting the SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 17:14 Aug 31, 2016 Jkt 238001 needs of American Indian and Alaska Native children and families, taking into consideration funding allocations, distribution formulas, and other issues affecting the delivery of Head Start services in that geographic location. In addition, OHS will share actions taken and in progress to address the issues and concerns raised in the 2016 OHS Tribal Consultation. The Consultation Session will be conducted with elected or appointed leaders of Tribal Governments and their designated representatives [42 U.S.C. 9835, Section 640(l)(4)(A)]. Designees must have a letter from the Tribal Government authorizing them to represent the tribe. Tribal Governments must submit the designee letter at least 3 days in advance of the Consultation Session to Angie Godfrey at Angie.Godfrey@acf.hhs.gov. Other representatives of tribal organizations and Native nonprofit organizations are welcome to attend as observers. A detailed report of the Consultation Session will be prepared and made available within 45 days of the Consultation Session to all Tribal Governments receiving funds for Head Start and Early Head Start programs. Tribes wishing to submit written testimony for the report should send testimony to Angie Godfrey at Angie.Godfrey@acf.hhs.gov either prior to the Consultation Session or within 30 days after the meeting. OHS will summarize oral testimony and comments from the Consultation Session in a report without attribution, along with topics of concern and recommendations. Dated: August 26, 2016. Blanca E. Enriquez, Director, Office of Head Start. announcement of the award of 13 single-source grants for a total of $35,513,938 under the W–F Alternative Program. The document contained an incorrect address and telephone number. FOR FURTHER INFORMATION CONTACT: Colleen Mahar-Piersma, Program Analyst, Office of Refugee Resettlement, Mary E. Switzer Building, 330 C Street SW., Washington, DC 20201. Telephone: 202–205–5266; Email: colleen.maharpiersma@acf.hhs.gov. Correction In the Federal Register of August 22, 2016, in FR Doc. 2016–19923, on page 56655, in the third column, correct the FOR FURTHER INFORMATION CONTACT caption to read: Colleen Mahar-Piersma, Program Analyst, Office of Refugee Resettlement, Mary E. Switzer Building, 330 C Street SW., Washington, DC 20201. Telephone: 202–205–5266; Email: colleen.mahar-piersma@ acf.hhs.gov. Mary M. Wayland, Senior Grants Policy Specialist, Division of Grants Policy, Office of Administration. [FR Doc. 2016–21038 Filed 8–31–16; 8:45 am] BILLING CODE 4184–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2016–N–0001] Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee, Renewal AGENCY: Food and Drug Administration, HHS. [FR Doc. 2016–21047 Filed 8–31–16; 8:45 am] BILLING CODE 4184–40–P Notice; renewal of advisory committee. ACTION: The Food and Drug Administration (FDA) is announcing the renewal of the Cardiovascular and Renal Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Cardiovascular and Renal Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until August 27, 2018. DATES: Authority for the Cardiovascular and Renal Drugs Advisory Committee will expire on August 27, 2016, unless the Commissioner formally determines that renewal is in the public interest. FOR FURTHER INFORMATION CONTACT: Jennifer Shepherd, Center for Drug Evaluation and Research, Food and SUMMARY: DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Announcement of the Award of SingleSource Grants Under the Wilson-Fish Alternative Program (W–F); Correction; CFDA Number: 93.583 Office of Refugee Resettlement, ACF, HHS. ACTION: Notice; correction. AGENCY: The Administration for Children and Families (ACF), Office of Refugee Resettlement (ORR), published a document in the Federal Register of August 22, 2016, concerning the SUMMARY: PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 E:\FR\FM\01SEN1.SGM 01SEN1

Agencies

[Federal Register Volume 81, Number 170 (Thursday, September 1, 2016)]
[Notices]
[Pages 60355-60356]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-21039]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Request for Nominations of Candidates To Serve on the Advisory 
Committee to the Director, Centers for Disease Control and Prevention 
(ACD, CDC)--Health Disparities Subcommittee (HDS)

    The Centers for Disease Control and Prevention (CDC) is soliciting 
nominations for possible membership on the ACD, CDC-HDS. This 
subcommittee consists of up to 16 experts in fields related to health 
policy, public health, global health, preparedness, preventive 
medicine, the faith-based and community-based sector, and allied fields 
who are selected by the CDC. The HDS provides interdisciplinary 
perspectives and subject matter expertise to the goal of reducing 
health disparities which may include research, program and policy 
analyses, and other developmental activities for the ACD, CDC on CDC's 
efforts to address health disparities which is integral to achieving 
the agency's overarching health impact goals. Specifically, the HDS 
will submit work products to the ACD, CDC for deliberation, discussion, 
and decision.
    Nominations are being sought for individuals who have expertise and 
qualifications necessary to contribute to the accomplishment of the 
subcommittee's mission. Nominees will be selected by the Designated 
Federal Officer of the ACD, CDC. Members may be invited to serve for 
terms of up to three years.
    The U.S. Department of Health and Human Services policy stipulates 
that committee membership shall be balanced in terms of professional 
training and background, points of view represented, and the 
committee's function. Appointments shall be made without discrimination 
on the basis of age, race, ethnicity, gender, sexual orientation, 
gender identity, HIV status, disability, and cultural, religious, or 
socioeconomic status. Nominees must be U.S. citizens, and cannot be 
full-time employees of the U.S. Government. Current participation on 
federal workgroups or prior experience serving on a federal advisory 
committee does not disqualify a candidate; however, HHS policy is to 
avoid excessive individual service on advisory committees and multiple 
committee memberships. Subcommittee members are Special Government 
Employees, requiring the filing of financial disclosure reports at the 
beginning and annually during their terms.
    Note that the need for different expertise varies from year to year 
and a candidate who is not selected in one year may be reconsidered in 
a subsequent year.
    Nominees must be U.S. citizens, and cannot be full-time employees 
of the U.S. Government. Candidates should submit the following items:
    [ssquf] Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address).
    [ssquf] At least one letter of recommendation from person(s) not 
employed by the U.S. Department of Health and Human Services. 
(Candidates may submit letter(s) from current HHS employees if they 
wish, but at least one letter must be submitted by a person not 
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
    Nomination materials must be date stamped by midnight on September 
30, 2016 and sent to: ACDirector@cdc.gov or to Tracie Strength, Office 
of the Chief of Staff, Centers for Disease Control and Prevention, 1600 
Clifton Road NE., Mailstop D14, Atlanta, Georgia 30329. Please direct 
questions to Tracie Strength at (404)498-6482.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and

[[Page 60356]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 2016-21039 Filed 8-31-16; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.